PF-07265807

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07265807, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of PF-07265807 in Participants With Metastatic Solid Tumors. [Phase 1]